본문 바로가기
KERD
논문KCI 등재

경도인지장애 환자의 장기간 한의약 치료 경과관찰 증례보고 2례

Long-Term Observations of Korean Medicine Treatment in Patients with Mild Cognitive Impairment: Two Case Reports

이고은|정문주|이나현|강형원|류영수|손성은
대한한방신경정신과학회 (The Korean Society Of Oriental Neuropsychiatry)|2021.09|동의신경정신과학회지 (The Korean Society of Oriental Neuropsychiatry)|제32권 제3호|pp. 285-302|DOI 10.7231/jon.2021.32.3.285

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

MCISNSB-2Long-term Korean medicine treatmentYisam-dan.
주제분류한의학

초록

Objectives: To examine the effect of long-term Korean medicine treatment on mild cognitive impairment (MCI). Methods: This study was conducted on two patients who were diagnosed with mild cognitive impairment and received long-term Korean medicine treatment. In order to evaluate the degree of cognitive decline, SNSB and K-MMSE were performed 2∼3 times at the first visit and during the treatment process. Results: Both cases 1 and 2 were diagnosed with MCI with a high possibility of developing dementia. In case 1, MCI progressed to early dementia at one year after the diagnosis of MCI. However, in case 2, that MCI status was maintained without progressing to dementia for 4 years after the diagnosis of MCI. The cause of such difference in the course of MCI might be attributed to the fact that Case 1 had lower K-IADL level but higher SGDS level than Case 2 at the time of initial diagnosis, with weak family support and irregular herbal medicine intake. Conclusions: Korean medicine treatment could improve and manage symptoms of cognitive decline due to MCI.

Abstract

Objectives: To examine the effect of long-term Korean medicine treatment on mild cognitive impairment (MCI). Methods: This study was conducted on two patients who were diagnosed with mild cognitive impairment and received long-term Korean medicine treatment. In order to evaluate the degree of cognitive decline, SNSB and K-MMSE were performed 2∼3 times at the first visit and during the treatment process. Results: Both cases 1 and 2 were diagnosed with MCI with a high possibility of developing dementia. In case 1, MCI progressed to early dementia at one year after the diagnosis of MCI. However, in case 2, that MCI status was maintained without progressing to dementia for 4 years after the diagnosis of MCI. The cause of such difference in the course of MCI might be attributed to the fact that Case 1 had lower K-IADL level but higher SGDS level than Case 2 at the time of initial diagnosis, with weak family support and irregular herbal medicine intake. Conclusions: Korean medicine treatment could improve and manage symptoms of cognitive decline due to MCI.

참고문헌 (40)

  1. Brodaty H, "Operationalizing the diagnostic criteria for mild cognitive impairment: The salience of objective measures in predicting incident dementia", American Journal of Geriatric Psychiatry, 25(5), pp.485~497 (2017)
  2. Rozzini L, "Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors", International Journal of Geriatric Psychiatry, 22(4), pp.356~360 (2007)
  3. Petersen RC, "Mild Cognitive Impairment: Aging to Alzheimer’s Disease", pp.15~40 (2003), Oxford university Press, Inc
  4. RC Petersen, "Current concepts in mild cognitive impairment", Archives of Neurology, 58(12), pp.1985~1992 (2001)
  5. Choi YJ, "Korean Traditional Medicine in Treating Patients with Mild Cognitive Impairment: A Multicenter Prospective Observational Case Series", Evidence-Based Complementary and Alternative Medicine, pp.1~12 (2020)
  6. 김우영, "경도인지장애의 비약물요법에 대한 고찰", 동의신경정신과학회지, 22(3), pp.1~11 (2011), 대한한방신경정신과학회
  7. Salloway S, "Efficacy of donepezil in mild cognitive impairment : a randomized placebo-controlled trial", Neurology, 63(4), pp.651~657 (2004)
  8. Petersen RC, "Vitamin E and donepezil for the treatment of mild cognitive impairment", N Engl J Med, 352(23), pp.2379~2388 (2005)
  9. Doody RS, "Donepezil treatment of patients with MCI : a 48-week randomized, placebo-controlled trial", Neurology, 72(18), pp.1555~1561 (2009)
  10. Jelic V, "Donepezil A Review of Pharmacological Characteristics and Role in the Management of Alzheimer Disease", Clinical Medicine Insights: Therapeutics, 2, pp.771~788 (2010)
  11. Min B, "Changes in cerebral glucose metabolism in patients with mild-to-moderate Alzheimer’s disease : a pilot study with the Chinese herbal medicine fuzhisan", Neurosci Lett, 501(1), pp.35~40 (2011)
  12. 이동윤, "치매 환자의 공격성 관리에 활용가능한 억간산(抑肝散)의 고전적, 비임상적, 임상적 근거현황", 동의신경정신과학회지, 32(2), pp.111~127 (2021), 대한한방신경정신과학회
  13. Hachinski VC, "Cerebral blood flow in dementia", Arch Neurol, 32(9), pp.632~637 (1975)
  14. Kang SJ, "Caregiver-Administrered Neuropsychiatric Inventory(CGA-NPI)", J Geriatri Psychiatry Neurol, 17(1), pp.32~35 (2004)
  15. 이고은, "한의학 병리적 노화 척도와 치매 한의학적 변증진단 개발 및 신뢰도 평가", 대한한의학회지, 38(3), pp.111~123 (2017), 대한한의학회[DOI]
  16. Petersen RC, "Mild cognitive Impairment", Continuum, 22(2), pp.404~418 (2016)
  17. Petersen RC, "Mild cognitive impairment : ten years later", Arch Neurol, 66(12), pp.1447~1455 (2009)
  18. Korolev IO, "Alzheimer’s Disease : A clinical and Basic Science Review", Medical Student Research Journal, 4, pp.24~33 (2014)
  19. Geslani DM, "Mild cognitive impairment : an operational definition and its conversion rate to Alzheimer’s disease", Dementia and Geriatric Cognitive Disorders, 19, pp.383~389 (2005)
  20. Kim TY, "The Conversion Rates Difference to the Alzheimer Dementia between the Normal Elderly Group and the Mild Cognitive Impairment Group in One Community Cohort : 18 Months’ Prospective Follow-up Study", J Korean Assoc Soc Psychiatry, 13(1), pp.10~16 (2008)
  21. U Ghafoor, "Effects of Acupuncture Therapy on MCI patients Using Functional Near-Infrared Spectroscopy", Frontiers in Aging Neuroscience, 11, pp.237~ (2019)
  22. Eun-Sun Jung, "Effect of acupuncture on patients with mild cognitive impairment assessed using functional near-infrared spectroscopy on week 12 (close-out): a pilot study protocol", Integrative Medicine Research, 7(3), pp.287~295 (2018), 한국한의학연구원[DOI]
  23. 김보민, "일개 한의의료기관 내 경도인지장애의 의한협진 매뉴얼 제안", 동의신경정신과학회지, 29(4), pp.239~253 (2018), 대한한방신경정신과학회[DOI]
  24. 강수진, "한국판 Instrumental Activities of Dalily Living의 타당도와 신뢰도", 대한신경과학회지, 20(1), pp.8~14 (2002), 대한신경과학회
  25. Fischer P, "Convertsion from subtypes of mild cognitive impairment to Alzheimer dementia", Neurology, 68(4), pp.288~291 (2007)
  26. Rountree SD, "Importance of subtle amnestic and nonamnestic deficits in mild cognitive impairment : prognosis and conversion to dementia", Dement Geriatr Cogn Disord, 24(6), pp.476~482 (2007)
  27. Tabert MH, "Neuropsychological prediction of conversion to Alzheimer disease in patients with mild cognitive impairment", Arch Gen Psychiatry, 63(8), pp.916~924 (2006)
  28. Luck T. Luppa M, "Prediction of incident dementia : impact of impairment in instrumental activities of daily living and mild cognitive impairment-results from the German study on ageing, cognition, and dementia in primary care patients", Am J Geiatr Psychiatry, 20(11), pp.943~954 (2021)
  29. Modrego PJ, "Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type : a prospective cohort study", Arch Neurol, 61, pp.1290~1293 (2004)
  30. Ge S, "Social support, social strain, and cognitive function among community-dwelling U.S. Chinese Older Adults", J Gerontol A Biol Sci Med Sci, 72(1), pp.16~21 (2017)
  31. Ozkan S, "Apraxia for differentiating Alzheimer’s disease from subcortical vascular dementia and mild cognitive impairment", Neuropsychiatr Dis Treat, 9, pp.947~951 (2013)
  32. Kim WJ, "Neuropsychological Differences between Mild Cognitive Impairment and Mild Alzheimer’s Disease", Dementia and Neurocognitive Disorders, 5, pp.12~17 (2006)
  33. 이승연, "알츠하이머 치매 및 경도인지기능장애 환자에서 나이, 성별,유전자형을 고려한 뇌 회백질 부피와 표준신경심리검사와의상관관계 연구", Investigative Magnetic Resonance Imaging, 17(4), pp.294~307 (2013), 대한자기공명의과학회[DOI]
  34. 박경애, "알츠하이머병과 경도인지장애 환자에서 이름대기 검사 수행 능력의 차이", Annals of geriatric medicine and research, 15(3), pp.135~143 (2011), 대한노인병학회
  35. 강형원, "LMK02의 품질규격화와 Aβ 올리고머에 의해 유도된 흰쥐해마 H19-7세포주에 미치는 항치매효과", 동의생리병리학회지, 23(2), pp.397~404 (2009), 한의병리학회
  36. Lim SJ, "Gugijihwang-Tang(PM012)decreases cognitive impairment and promotes neurogenesis in the 3xTg AD transgenic mice", pp.2014
  37. 김우영, "한의학의 치매관련 임상연구 동향분석과 제안", 한국한의학연구원논문집, 17(2), pp.39~46 (2011), 한국한의학연구원
  38. Choi YJ, "Korean Traditional Medicine in Treating Patients with Mild Cognitive Impairment:A Multicenter Prospective Observational Case Series", Evidence-Based Complementary and Alternative Medicine, pp.1~12 (2020)
  39. Jang GB., "Korean translation of Kyungakjeinseo", pp.846~ (1992), Iljungsa
  40. Korean Psychosomatic Society, "Psychosomatic medicine", pp.324~333 (2007), Jipmoondang

관련 논문AI추천

지역사회 거주 경도인지장애 노인들을 대상으로 시행한한의치료의 보고: 인지기능을 중심으로김윤나, 배준상, 엄윤지, 윤현민, 이경석, 조성훈대한한방신경정신과학회 · 동의신경정신과학회지2019 · 제30권 제3호구기지황탕 투여 후 호전된 경도인지장애 환자 1례에 대한 증례보고강석만, 김경순, 박미소, 성현주, 유대원, 유호룡, 정광렬, 채인철대한한방내과학회 · 대한한방내과학회지2021 · 제42권 제5호일개 한의의료기관 내 경도인지장애의 의한협진 매뉴얼 제안강형원, 김보민, 설재욱, 손성은, 송민영, 이가원, 임정태, 조희근, 최성열대한한방신경정신과학회 · 동의신경정신과학회지2018 · 제29권 제4호증례를 통해 본 치매의 한양방 협진 모델 연구강형원, 양현덕, 이고은, 전원경대한한방신경정신과학회 · 동의신경정신과학회지2013 · 제24권 제3호한양방 협진치료를 받은 치매와 경도인지장애 환자에 대한 후향적 의무기록 분석강형원, 김남권, 김진원, 이고은, 이성익, 정문주대한한방신경정신과학회 · 동의신경정신과학회지2018 · 제29권 제2호치매의 한약물 치료에 대한 체계적 임상논문 고찰 - 국내문헌을 중심으로 -권용주, 조성훈, 조혜영, 황의완대한한방신경정신과학회 · 동의신경정신과학회지2010 · 제21권 제4호

이 간행물의 다른 논문 (10건)

불면증에 대한 약침 치료 현황 조사 연구김보경, 임정화, 조준희, 최성열pp. 141-154핵심감정척도 단축형과 MMPI-2의 상관성 연구이재혁, 신혜규pp. 155-166사상성격검사(SPQ)의 한의학적 활용 현황에 대한 체계적 문헌 분석김종우, 박소정, 채한, 김민성, 황요순, 이준희, 이수진pp. 167-184불면 장애에 대한 약침술 치료법 제안을 위한 체계적 문헌 고찰과 메타 분석 연구조민우, 김보경, 임정화pp. 185-206‘기공’의 국외 임상연구 최신동향: 스코핑 고찰을 중심으로 한 예비연구최원영, 김종우, 서효원pp. 207-217
원문 보기